Bluejay Diagnostics, Inc.Bluejay Diagnostics, Inc.Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc.

No trades
See on Supercharts
Market capitalization
‪1.48 M‬USD
−9.1848USD
‪−9.95 M‬USD
‪1.69 M‬
Beta (1Y)
−0.08

About Bluejay Diagnostics, Inc.

CEO
Indranil Dey
Headquarters
Acton
Employees (FY)
10
Founded
2015
ISIN
US0956333019
FIGI
BBG012TKJCJ1
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BJDX is 0.5500 USD — it has decreased by 0.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bluejay Diagnostics, Inc. stocks are traded under the ticker BJDX.
Bluejay Diagnostics, Inc. is going to release the next earnings report on Apr 22, 2024. Keep track of upcoming events with our Earnings Calendar.
BJDX stock is 7.27% volatile and has beta coefficient of −0.08. Check out the list of the most volatile stocks — is Bluejay Diagnostics, Inc. there?
BJDX earnings for the last quarter are −2.08 USD per share, whereas the estimation was −0.82 USD resulting in a −155.21% surprise. The estimated earnings for the next quarter are −0.52 USD per share. See more details about Bluejay Diagnostics, Inc. earnings.
Yes, you can track Bluejay Diagnostics, Inc. financials in yearly and quarterly reports right on TradingView.
BJDX stock has fallen by 21.42% compared to the previous week, the month change is a 32.94% fall, over the last year Bluejay Diagnostics, Inc. has showed a 92.00% decrease.
BJDX net income for the last quarter is ‪−2.30 M‬ USD, while the quarter before that showed ‪−2.30 M‬ USD of net income which accounts for −0.21% change. Track more Bluejay Diagnostics, Inc. financial stats to get the full picture.
No, BJDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BJDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bluejay Diagnostics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
BJDX reached its all-time high on Nov 10, 2021 with the price of 125.0000 USD, and its all-time low was 0.4703 USD and was reached on Apr 16, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 10.00 employees. See our rating of the largest employees — is Bluejay Diagnostics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bluejay Diagnostics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bluejay Diagnostics, Inc. stock shows the sell signal. See more of Bluejay Diagnostics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.